Dyadic-Based Diagnosis, Care, and Prevention for HIV Discordant Couples in Tanzania (DDCP)

This is a prospective observational study of couples in Kisarawe, Tanzania who will be provided an intervention that offers: (1) HIV self-testing kits and pre-test counseling provided at the household, (2) linkage to a counseling and referral center for those who test positive, (3) facilitated enrollment to care and treatment for couples with confirmed HIV infection; and (4) access to pre-exposure prophylaxis for the negative partner in a HIV sero-discordant couple. We will identify HIV sero-discordant couples through the HIV self-testing component, and through identifying discordant couples at the local HIV clinic. HIV sero-discordant couples (N=64 couples) will be administered a baseline, 6- ,12-, and 18-month survey, and the investigators will collect ongoing clinical data from each clinic visit. Biometric data (fingerprint) will be collected at enrollment, and all encounters with the counseling and referral center, and HIV treatment center, to allow linking of utilization of services with survey data.

Study Overview

• Status: Completed
• Conditions: HIV
• Intervention / Treatment: Behavioral: HIV Self-Testing; Behavioral: Immediate Access to ART for HIV infected couple members; Behavioral: Access to PrEP for HIV uninfected couple members

Detailed Description

The investigators propose to conduct a prospective observational study of cohabitating couples aged 18 years and above in Kisarawe, Tanzania who will be provided: (1) distribution of HIV self-testing kits to cohabitating couples; (2) linkage to confirmatory HIV-testing & counseling for those who test HIV-positive; (3) facilitated enrollment to care and treatment for those couples with confirmed HIV infection; and (4) for HIV serodiscordant couples, access to PrEP for the HIV-negative partner. A baseline survey, and a follow-up survey approximately 2 weeks later and HIV test, will be administered to all couples involved in the self-testing phase of the study. A cohort of 60 to 70 HIV serodiscordant couples will receive a survey at baseline 6-, 12-, and 18-month survey, and the investigators will collect ongoing clinical data from each clinic visit. Biometric data (fingerprint) will be collected at study and intervention encounters to link utilization of services with survey data. The investigators will also enroll serodiscordant couples from patients already receiving care from the Kisarawe Care and Treatment Center (CTC).

The specific AIMS evaluate 4 key strategic goals, including:

1. HIV Self-Testing for Stable Couples: (a) assess the acceptability, safety, and factors associated with uptake of HIV self-testing; and (b) determine the proportion of clients testing positive for HIV via self-testing who engage in care.
2. Dyadic Engagement of Sero-Discordant Couples in Care & Prevention: (a) establish the proportion of sero-discordant couples who will enroll in HIV care as a dyad, (b) determine the effect of dyadic care enrollment on HIV care retention and ART adherence, and (c) assess reduction in risk of acquiring HIV infection for the negative partner.
3. Pre-Exposure Prophylaxis (PrEP): (a) establish the proportion and characteristics of HIV negative clients in a sero-discordant relationship who opt to take PrEP, (b) determine how engaging in ARV treatment by the positive partner affects PrEP utilization by the negative partner, and vice versa, and (c) Identify patterns and correlates of risk reduction strategies that couples in care utilize over time (abstinence, ARV for positive partner, PrEP for negative partner, condom use).
4. Operational: (a) determine Dyadic-based Diagnosis, Care, & Prevention (DDCP) program cost and economic efficiency, (b) compare DDCP to clinic-based and mobile VCT with regard to cost and efficiency for testing and linkage to care, and (c) assess the feasibility, acceptability, safety, and utility of using biometric data to track service utilization.

• Study Type: Observational
• Enrollment (Actual): 128

Contacts and Locations

Study Locations

• Tanzania
  • Pwani
    • Dar Es Salaam, Pwani, Tanzania
      • Muhimbili University of Health and Allied Programs

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 55 years (Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Cohabitating couples aged 18 to 55 years of age, residing in Kisarawe Town, Tanzania. Our cohort will be comprised of HIV sero-discordant couples.

Description

Inclusion Criteria:

To be eligible for participation in the self-testing cohort, each individual has to be:

1. age 18 years or older (and at least one member of the couple has to be aged 55 years or below),
2. live in the household regularly,
3. have no plans for moving from the area before the follow up period.

To be eligible for the prevention and care portion of the study, couples must be:

1. in an HIV sero-discordant relationship,
2. pregnant or breastfeeding women will be allowed to enroll in the study after counseling on the risks and benefits is provided,
3. HIV-negative women who are pregnant or breastfeeding will be allowed to take PrEP after counseling on the risks and benefits is provided.

Exclusion Criteria:

Couples will not be eligible for enrolled in the sero-discordant sub-cohort if:

1. the HIV-negative member has signs of advanced kidney disease (measured by serum creatinine),
2. the HIV-negative partner has Hepatitis B and markers of poor liver functioning (measured by alanine aminotransferase).

Study Plan

How is the study designed?

Design Details

• Observational Models: Cohort
• Time Perspectives: Prospective

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort

Intervention / Treatment

Sero-discordant Couple Cohort; We will enroll and track a cohort of 60 serodiscordant couples (120 individuals). The HIV-positive couple members will be offered anti-retroviral therapy (ART) and the HIV-negative couple members will be offered pre-exposure prophylaxis (PrEP). We will monitor monthly clinic visits for the couple and will conduct in-depth behavioral surveys at baseline, 6-, 12-, and 18-months.

Behavioral: HIV Self-Testing; Access to home-based HIV self-testing kits for stable couples.; Behavioral: Immediate Access to ART for HIV infected couple members; Immediate access to ART for HIV infected couple members (per current Tanzanian standard of care).; Behavioral: Access to PrEP for HIV uninfected couple members; Access to PrEP for HIV uninfected couple members.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Utilization of HIV Self-Test Kits	The proportion of eligible individuals who received an HIV self-test kit who successfully used the kit within two weeks of receiving the test kit.	2 weeks
Sharing of HIV Test Results with Primary Partner	The self-reported proportion of study participants who told their primary partner the results of the HIV test generated by the self-test kit.	18 months
Proportion of HIV Sero-discordant Couples who Engage in HIV Care Together	Proportion of HIV Sero-discordant Couples who Engage in HIV Care Together	18 months
Adherence to ART Among HIV Infected Members of Sero-discordant Couples	Self-reported proportion of doses of ART medication successfully taken on recommended schedule.	18 months
Retention in ART Care	Having ≥2 outpatient visits at least 3 months apart per year	18 months
Uptake of PrEP	Proportion of eligible HIV-uninfected cohort members who opt to take PrEP	18 months
Uptake of ARVs	Proportion of eligible HIV-infected cohort members who opt to take ART	18 months
Adherence to ART prescription refills among HIV infected members of sero-discordant couples	Proportion of ART prescriptions successfully filled based on pharmacy records among HIV-infected members of sero-discordant couples.	18-Months
HIV Viral Load	Copies per mL of HIV detected in blood sample.	18-months
Reduction in HIV-related Risk Behaviors	Self-reported number of sexual partners.	18 months
Reduction in sex with non-primary sex partners	Any self-reported sex with non-primary sexual partner.	18-Months
Reduction in sex acts	Self-reported number of vaginal and anal sex acts.	18-months
Reduction in unprotected sex	Self-reported proportion of vaginal and anal sex acts in which a condom was used.	18-months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Program cost per client served	Program cost per client served	18 months

Collaborators and Investigators

• Sponsor: Medical University of South Carolina
• Collaborators: National Institute of Mental Health (NIMH)

Study record dates

Study Major Dates

• Study Start (Actual): November 21, 2017
• Primary Completion (Actual): September 7, 2020
• Study Completion (Actual): September 7, 2020

Study Registration Dates

• First Submitted: March 22, 2017
• First Submitted That Met QC Criteria: March 27, 2017
• First Posted (Actual): April 4, 2017

Study Record Updates

• Last Update Posted (Actual): February 7, 2022
• Last Update Submitted That Met QC Criteria: January 21, 2022
• Last Verified: January 1, 2022

More Information

Terms related to this study

• Keywords: Tanzania; Self-testing; Pre-exposure Prophylaxis; Serodiscordant
• Other Study ID Numbers: R01MH106369-01 (U.S. NIH Grant/Contract); R01MH106369 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No

Drug and device information, study documents

• Studies a U.S. FDA-regulated device product: No